Germany’s BioNTech to buy Chinese firm with promising cancer drug
13 November 2024
Health
Berlin, Germany – Germany pharmaceutical company BioNTech, which shot to global prominence after its early coronavirus vaccine, has boosted its cancer drug development by agreeing to buy Chinese firm …